The Stump the Hepatologist session demonstrates the "art" behind the science of working through a differential diagnosis. Through live interactions with case presenters, hepatology experts work through interesting and challenging cases, voicing their thought process as the case unfolds. Participants witness how experts in the field, using their knowledge base, break down and narrow their differential diagnosis to solve the case. Following determination of the final diagnosis, each case presenter provides a brief synopsis of relevant literature.

This session updates the community on the experience and expertise of patient engagement from 3 ongoing collaboratives:
<ul>
<li>The Autoimmune Liver Disease Network for Kids (A-LiNK) and the A-LiNK connections&nbsp;</li>
<li>PFIC.org and their Patient-Centered Outcomes Research Institute (PCORI) funded IMPACT project (<u><strong>i</strong></u>dentifying research targets by <u><strong>m</strong></u>erging <u><strong>p</strong></u>atient <u><strong>a</strong></u>nd <u><strong>c</strong></u>linician <u><strong>t</strong></u>reatment information)</li>
<li>the Starzl Network for Excellence in Pediatric Transplantation and their PCORI funded PARTNER AD³vance project&nbsp;(<u><strong>pa</strong></u>tient-centered <u><strong>r</strong></u>esearch in pediatric <u><strong>t</strong></u>ranspla<u><strong>n</strong></u>t&mdash;<u><strong>e</strong></u>ngaging families and <u><strong>r</strong></u>ecipients&mdash;<u><strong>ad</strong></u>olescent and young <u><strong>ad</strong></u>ult <u><strong>ad</strong></u>visors)</li>
</ul>
Presenters highlight the importance of patient engagement in setting research agendas, strategies for successful patient engagement, and how patient engagement affects project development and progress.

Portal hypertension remains a challenging complication of pediatric liver disease with significant morbidity and mortality. Management of portal hypertension in adults and children can vary. This session reviews the diagnosis and management of pediatric portal hypertension, learning from adult data.

The Associates Course expands the knowledge base of participants to improve patient outcomes in behavioral, nutritional, and pharmacologic interventions in chronic liver disease. Speakers explore topics including: (1) novel treatment models of chronic hepatitis C and MASLD/MASH; (2) pharmacist driven management of chronic liver disease; (3) resource-limited management of chronic liver disease; and (4) palliative approaches to management of patients with chronic liver disease.

Join us for a poster highlight of the top abstracts from the ACLF SIG.&nbsp;<br />
&nbsp;

Artifical intelligence (AI) affects multiple areas of our lives as clinicians, researchers, and patients. This session focuses on the rapidly evolving role of AI in liver disease care. Experts address (1) the potential role of AI in predicting disease progression, treatment response, and long-term outcomes; (2) limitations and challenges in the use of AI in the liver care setting; and (3) how AI is influencing communication between clinicians and their patients.

Join the Liver Fellows Network for a live podcast recording of&nbsp;<em>Liver Talks</em>, the official podcast of the Liver Fellow Network. In this special episode, &ldquo;Tips for TIPS&rdquo;, we will explore a complex case of portal hypertension through an engaging, case-based discussion with expert hepatologists Dr. Brett E. Fortune and Dr. David E. Kaplan.<br />
&nbsp;

Come discuss the upcoming AASLD guideline on treatment of chronic hepatitis B with the co-chairs of the guideline. What has changed?<br />
&nbsp;<br />
9:45-9:55 AM- Presentation<br />
9:55-10:15 AM- Audience Q&amp;A and Discussion<br />
&nbsp;<br />
&nbsp;

The Patient Engagement in Drug Development: Leading Through Example (PEDDLE) Working Group, an initiative of the Liver Forum, is developing tools and best practices to make patient engagement a consistent part of MASH drug development. This session will introduce the Patient Engagement Toolkit, a framework designed to guide how patient perspectives are integrated across all stages of clinical research. Speakers will discuss how PEDDLE&rsquo;s work connects with FDA guidance on non-invasive tests (NITs) and current discussions around diversity and trial representation. Co-chairs from a patient organization and industry will discuss how structured patient engagement can enhance recruitment, retention, data relevance, and trust in developing effective MASH therapies.<br />
<br />
<strong>Zoom:</strong> <a href="https://us02web.zoom.us/webinar/register/WN_FHLtwb2VSc6geLfq21aOuA">htt…;

As the majority of transplant hepatology trainees are women, it is essential to focus on recruiting and retaining this talented group to ensure a thriving hepatology division. Evidence highlights that workplace bias, family-unfriendly work environments, and gender pay inequities are significant challenges that need to be addressed. This community conversation begins with a brief expert review of the evidence behind workplace gender inequities and exploration of successful structural solutions. A diverse panel—including division chiefs with successful recruitment records, a female fellow trainee, an early-career female physician, and a mid-career female physician—then share their experiences with fellowship applications and job searches.